Cabot Corporation
Last updated September 27, 2026
Organization details
- Legal name
- Cabot Corporation
- Ownership
- Public
- Status
- Active
- SIC code
- 2890 — Miscellaneous Chemical Products
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- CBT
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000016040
- EIN
- 04-2271897
Board of directors
-
Cabot Juan Enriquez · DirectorSince 2023
-
Christine Y. Yan · DirectorSince 2023
-
Cynthia A. Arnold · DirectorSince 2023
-
Douglas G. Delgrosso · DirectorSince 2023
-
Frank Anders Wilson · DirectorSince 2023
-
Matthais L. Wolfgruber · DirectorSince 2023
-
Michael M. Morrow · DirectorSince 2023
-
Michelle Elizabeth Williams · DirectorSince 2023
-
Raffiq Nathoo · DirectorSince 2023
-
Sean D. Keohane · Director · President and CEOSince 2023
-
Sue H. Rataj · DirectorSince 2023
-
Thierry Fj Vanlancker · DirectorSince 2024
-
William C. Kirby · DirectorSince 2023
Chief executives
Sean D. Keohane
· President and CEO
Dates unknown
Director election results
Annual meeting of March 12, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.6%
-
96.9%
-
98.8%
Board connections
9 of this board's directors also sit on 12 other boards.
- via Douglas G. Delgrosso
- via Sue H. Rataj
- via Frank Anders Wilson
- via Raffiq Nathoo
- via Michelle Elizabeth Williams
- via Cynthia A. Arnold
- via Douglas G. Delgrosso
- via Christine Y. Yan
- via Frank Anders Wilson
- via Christine Y. Yan
- via Sean D. Keohane
- via William C. Kirby
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $19,646,314
- 3 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 28, 2026 | Sean D. Keohane Director, Officer (President and CEO) | Option exercise | +134,895 | $50.00 | $6,744,750 |
| Aug 28, 2026 | Sean D. Keohane Director, Officer (President and CEO) | Open-market sale | −134,895 | $85.00 | $11,466,075 |
| Aug 24, 2026 | Sean D. Keohane Director, Officer (President and CEO) | Option exercise | +2,779 | $50.00 | $138,950 |
| Aug 24, 2026 | Sean D. Keohane Director, Officer (President and CEO) | Open-market sale | −2,779 | $85.50 | $237,605 |
| Aug 7, 2026 | Sean D. Keohane Director, Officer (President and CEO) | Option exercise | +91,923 | $62.24 | $5,721,288 |
| Aug 7, 2026 | Sean D. Keohane Director, Officer (President and CEO) | Open-market sale | −91,923 | $86.41 | $7,942,634 |
| Jan 8, 2026 | Cabot Juan Enriquez Director | Grant or award | +486 | — | — |
| Jan 8, 2026 | Douglas G. Delgrosso Director | Grant or award | +2,298 | — | — |
| Jan 8, 2026 | Raffiq Nathoo Director | Grant or award | +2,298 | — | — |
| Jan 8, 2026 | Michelle Elizabeth Williams Director | Grant or award | +2,298 | — | — |
| Jan 8, 2026 | Christine Y. Yan Director | Grant or award | +2,298 | — | — |
| Jan 8, 2026 | Cynthia A. Arnold Director | Grant or award | +2,298 | — | — |
| Jan 8, 2026 | Thierry Fj Vanlancker Director | Grant or award | +2,298 | — | — |
| Jan 8, 2026 | Michael M. Morrow Director | Grant or award | +2,298 | — | — |
| Jan 8, 2026 | Frank Anders Wilson Director | Grant or award | +2,298 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.